COMMUNIQUÉS West-GlobeNewswire

Orum Therapeutics Doses First Patient in Phase 1 Trial of ORM-1153, a CD123-GSPT1 Degrader-Antibody Conjugate
14/10/2026
BOSTON and DAEJEON, South Korea, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today [...]
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
14/10/2026
-- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price list -- -- IMCIVREE is the first approved therapy in Japan for patients living [...]
Assisting Hands Home Care - The Villages Doubles in Size in 2026 as Demand for In-Home Care Grows
13/10/2026
Following its 2025 Top Producer Award, the local agency has doubled its clients served, caregiving team, and service capacity while expanding care for elderly, veterans and individuals with special needs. The Villages, [...]
Lite Strategy Marks 15 Years of Litecoin with Launch of "Proof of Time" Public Industry Archive
13/10/2026
First Nasdaq-Listed Company with Litecoin Reserve Treasury Celebrates 15 Years of Uptime and Real-World Payments with an Industry-Wide Storytelling Campaign SAN DIEGO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, [...]
Shoreline Medical Administration, CHUM Health and Cellution Biologics Launch Elite Graft Program for Advanced Wound Care
13/10/2026
New collaborative program brings together an industry leading biologic graft, wound care specific revenue cycle management and the only clawback protection program in one coordinated solution ROSWELL, Ga., Oct. 13, 2026 [...]
Eye2Eye Foundation Announces Free Thyroid Eye Disease Patient Seminars in Houston and Woodland Hills Featuring Dr. Raymond Douglas
13/10/2026
Complimentary gatherings in Houston and Woodland Hills will connect people affected by thyroid eye disease with clinical experts, patient-focused education and practical financial-navigation guidance. Beverly Hills, CA [...]
Giraffe Bio raises $6.4M Seed to scale next-generation reagents for copper mining
13/10/2026
Funding will accelerate manufacturing scale-up and industrial validation of drop-in biochemical flotation reagents designed to help miners recover more copper from increasingly complex ores BUENOS AIRES, Argentina and [...]
Stride Autism Centers Expands Early Intervention ABA Access with New Chicago Location
13/10/2026
Avondale–Logan Square center now accepting children ages 2–6 for individualized, center-based ABA therapy CHICAGO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of Applied Behavior Analysis [...]
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
13/10/2026
Acquisition of Velaris and concurrent oversubscribed $350 million private placement positions the Company to deliver multiple proof-of-concept datasets in pulmonary arterial hypertension Velaris Therapeutics, the ninth [...]
Johns Hopkins Health Plans Named Corporate Champion by The Tree House Child Advocacy Center
13/10/2026
Recognition Honors Support for Critical Medical Services for Children in Montgomery County HANOVER, Md., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has been named a Corporate Champion by The Tree House [...]
Texas Legends, Block Party Energy, and One Big Ribbon: Ally Medical ER Frisco Makes It Official
13/10/2026
Neighbors, families, and community leaders joined Ally Medical ER for an evening of food, fun, and celebration at the city’s newest emergency room FRISCO, Texas, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency [...]
BayCare Celebrates a Decade as a Fortune Best Workplace in Health Care™
13/10/2026
CLEARWATER, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Great Place To Work® and Fortune magazine have named BayCare Health System to the national list of 2026 Fortune Best Workplaces in Health Care. This marks the 10th [...]
Standard Process® Announces Launch of MediHerb® GLP-1 Bitter Complex
13/10/2026
New herbal formula combines Hops and Feverfew extracts to support satiety, healthy digestion, and metabolism through the body’s natural response to bitter ingredients.* A Media Snippet accompanying this announcement is [...]
Alignment Health Expands Medicare Advantage Coverage to Four New Charlotte-Area Counties for 2027
13/10/2026
Expansion brings Alignment's coordinated care model, access to Novant Health and Tryon Medical Partners, and new Medicare Advantage plan options to more than 295,000 additional Medicare beneficiaries CHARLOTTE, N.C., [...]
Reflect Scientific Introduces PF-90 Blast Plate Freezer, Combining Two Freezing Technologies for Biopharmaceutical and Cell Therapy Applications
13/10/2026
OREM, Utah, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), through its Cryometrix brand, today announced the launch of the PF-90 Blast Plate Freezer, a next-generation ultra-low temperature [...]
MediPharm Labs Expands Its International Medical Cannabis Footprint with First CBD Metered-Dose Inhaler Shipment to Panama
13/10/2026
MediPharm has completed its first shipment to Adeiwa Pharma, which will distribute the product to patients in Panama. TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ [...]
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
13/10/2026
AUSTIN, Texas and DURHAM, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potential first-in- [...]
Novastra Therapeutics to Present Initial Phase 1 Data for OAP-101 in Anti–PD-1–Refractory Advanced Melanoma at ESMO Congress 2026
13/10/2026
First clinical data for OAP-101, built on proprietary OmniAntigen™ Platform (OAP) OAP enables systematic immune reprogramming therapy (XIRT™) to overcome resistance of cold solid tumors to current therapies, including [...]
Tenvie Therapeutics Announces First Subject Dosed in Phase 1 Trial of TNV313, Expanding Its Fully CNS-Penetrant NLRP3 Franchise
13/10/2026
Third drug candidate from Tenvie’s product engine to enter clinical development in 2026 TNV313 joins TNV262 to give Tenvie two clinical-stage, fully CNS-penetrant NLRP3 inhibitors, enabling parallel development across [...]

Pages